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Abstract
Background
Neutropenia increases the risk of infection, but it is unknown if this also applies to lymphope-
nia. We therefore tested the hypotheses that lymphopenia is associated with increased risk
of infection and infection-related death in the general population.
Methods and findings
Of the invited 220,424 individuals, 99,191 attended examination. We analyzed 98,344 indi-
viduals from the Copenhagen General Population Study (Denmark), examined from
November 25, 2003, to July 9, 2013, and with available blood lymphocyte count at date of
examination. During a median of 6 years of follow-up, they developed 8,401 infections and
experienced 1,045 infection-related deaths. Due to the completeness of the Danish civil and
health registries, none of the 98,344 individuals were lost to follow-up, and those emigrating
(n = 385) or dying (n = 5,636) had their follow-up truncated at the day of emigration or death.
At date of examination, mean age was 58 years, and 44,181 (44.9%) were men. Individuals
with lymphopenia (lymphocyte count < 1.1 × 109/l, n = 2,352) compared to those with lym-
phocytes in the reference range (1.1–3.7 × 109/l, n = 93,538) had multivariable-adjusted
hazard ratios of 1.41 (95% CI 1.28–1.56) for any infection, 1.31 (1.14–1.52) for pneumonia,
1.44 (1.15–1.79) for skin infection, 1.26 (1.02–1.56) for urinary tract infection, 1.51 (1.21–
1.89) for sepsis, 1.38 (1.01–1.88) for diarrheal disease, 2.15 (1.16–3.98) for endocarditis,
and 2.26 (1.21–4.24) for other infections. The corresponding hazard ratio for infection-
related death was 1.70 (95% CI 1.37–2.10). Analyses were adjusted for age, sex, smoking
status, cumulative smoking, alcohol intake, body mass index, plasma C-reactive protein,
blood neutrophil count, recent infection, Charlson comorbidity index, autoimmune diseases,
medication use, and immunodeficiency/hematologic disease. The findings were robust in all
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002685 November 1, 2018 1 / 22
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Warny M, Helby J, Nordestgaard BG,
Birgens H, Bojesen SE (2018) Lymphopenia and
risk of infection and infection-related death in
98,344 individuals from a prospective Danish
population-based study. PLoS Med 15(11):
e1002685. https://doi.org/10.1371/journal.
pmed.1002685
Academic Editor: Marcus Altfeld, Heinrich Petter
Institute, GERMANY
Received: May 28, 2018
Accepted: October 2, 2018
Published: November 1, 2018
Copyright: © 2018 Warny et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: The Danish Data
Protection Agency does not allow us to deposit
individual participant data underlying this study,
but the steering committee of the Copenhagen
General Population Study considers all
collaboration requests. Point of contact for data
access is Anne Birgitte Hjuler Ammari, anne.
birgitte.hjuler.ammari@regionh.dk, Chief of section
for the Copenhagen City Heart Study, and member
of the committee of the Copenhagen General
Population Study.
stratified analyses and also when including only events later than 2 years after first examina-
tion. However, due to the observational design, the study cannot address questions of cau-
sality, and our analyses might theoretically have been affected by residual confounding and
reverse causation. In principle, fluctuating lymphocyte counts over time might also have
influenced analyses, but lymphocyte counts in 5,181 individuals measured 10 years after
first examination showed a regression dilution ratio of 0.68.
Conclusions
Lymphopenia was associated with increased risk of hospitalization with infection and
increased risk of infection-related death in the general population. Notably, causality cannot
be deduced from our data.
Author summary
Why was this study done?
• Neutropenia and lymphopenia are low concentrations in the blood of the white blood
cells—neutrophil granulocytes and lymphocytes, respectively; both are important for
protecting against infections.
• Individuals with neutropenia have a well-documented increased risk of infection.
• It is currently unknown whether lymphopenia is associated with risk of infection in
individuals from the general population.
What did the researchers do and find?
• We investigated whether a low lymphocyte count could predict risk of later hospitaliza-
tion due to an infection or risk of death due to an infection.
• The study population consisted of 98,344 individuals from the general population in
Copenhagen, Denmark. All included individuals answered a questionnaire on lifestyle
and health, had a physical examination, and had blood samples drawn at the date of
examination.
• We found that lymphopenia in the general population was associated with a 1.4-fold
increased risk of infection and a 1.7-fold increased risk of infection-related death.
What do these findings mean?
• The study design cannot address questions of causality; however, risk of infection was
increased in individuals with lymphopenia even 2 years after blood sampling, indicating
that undiagnosed infection or comorbidity is not likely to be the only explanation for
the results.
Lymphopenia and risk of infections
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• Physicians are generally not recommended to intervene in patients with lymphopenia
without an associated diagnosed disease. This might deserve reconsideration, since indi-
viduals with lymphopenia have increased risk of infection and infection-related death.
Introduction
Neutropenia (neutrophil count< 0.5 × 109/l) is associated with increased risk of infection
[1,2], and the risk increases with lower and lower neutrophil counts [3,4]. In contrast, it is
unknown whether lymphopenia also is associated with increased risk of infection in individu-
als from the general population. Importantly, physicians are generally not recommended to
intervene in patients with lymphopenia without an associated diagnosed disease. Lymphope-
nia in the general population is typically discovered by chance when doing routine blood
examination, and is often managed by the general practitioner. If asymptomatic, these patients
are usually not referred for further examination, and isolated lymphopenia is generally not
considered as threatening as neutropenia.
Lymphopenia may be caused by primary conditions such as congenital immunodeficiency
disorders [5] or secondary causes such as malnutrition [6], alcohol abuse [7,8], medications
[9], malignancies [10–12], systemic autoimmune diseases [13–15], and infections [13,16,17].
Diseases that cause lymphopenia are typically associated with an increased predisposition to
various infections, either directly as a result of the lymphopenia-associated immune suppres-
sion or because of the underlying disease.
In this study, which included 98,344 individuals from the general population, we tested the
hypotheses that lymphopenia is associated with increased risk of infection and infection-
related death.
Methods
Participants
We studied 98,344 individuals from the prospective Copenhagen General Population Study
[18–20], recruited from November 25, 2003, to July 9, 2013 (Fig 1). Individuals aged 20–100
Fig 1. Flow chart of individuals from the Copenhagen General Population Study.
https://doi.org/10.1371/journal.pmed.1002685.g001
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years were invited from the general population, using the Danish Civil Registration System
[21]. At the date of examination, all individuals completed a questionnaire on lifestyle and
health (S1 and S2 Texts), had a physical examination, and provided blood samples. All individ-
uals were white and of Danish descent. Due to the completeness of the Danish civil and health
registries, no individuals were lost to follow-up, and those emigrating (n = 385) or dying (n =
5,636) had their follow-up truncated at the day of emigration or death. Individuals with a total
leukocyte count above 50 × 109/l were advised to contact their general practitioner for further
evaluation. The study was approved by a Danish ethical committee (H-KF-01-144/01), and all
participants gave written informed consent.
Covariates
All included covariates were chosen based on previous studies reporting them to be associated
with lymphopenia [7,22–24] and with risk of infection [25–27]. Information on age and sex
was acquired from the Danish Civil Registration System, whereas information on smoking sta-
tus (current/former/never), cumulative smoking in pack-years (with 1 pack-year defined as 20
cigarettes or equivalent smoked per day for a year), alcohol consumption (none/moderate/
heavy, with heavy consumption defined as>168 g/week for men and>84 g/week for women,
as recommended by the Danish Health Authority), body mass index (measured weight in kilo-
grams divided by the measured height in meters squared, categorized into 6 groups:�18.5/
18.6–25.0/25.1–30.0/30.1–35.0/35.1–40.0/>40.0), recent infection within the last 4 weeks
before the date of examination (including acute fever, bronchitis, and/or urinary tract infec-
tion), and medication use (any medication use or no medication use, with vitamins and herb-
als regarded as no medication use) were derived from the questionnaire and physical
examination [18]. The categorizations of quantitative variables were done using conventional
cutoffs to ease interpretation.
As a marker of inflammation, plasma C-reactive protein level was measured at the date of
examination using standard high-sensitivity hospital assays. Blood neutrophil count was mea-
sured as part of the white blood cell differential count.
Blood lymphocyte count
Blood samples were collected in EDTA tubes at the date of examination, and white blood cell
counts were measured on fresh samples shortly after blood draw using the ADVIA 120 Hema-
tology System. Precision of the measurements was monitored by daily measurements on inter-
nal control samples, while accuracy was monitored monthly using external control samples
from a Scandinavian quality control program. The day-to-day coefficient of variation of the
internal control was typically 2%–4% in the range of 25 × 109/l.
Internationally, there is no consensus on the definition of lymphopenia. The cutoff value
varies slightly between laboratories, but lymphopenia is commonly defined as a lymphocyte
count below 1.0–1.5 × 109/l [15,28,29]. In this study, we examined a general population cohort
including both healthy and ill individuals, and we chose to categorize lymphocyte counts
below the 2.5th percentile as lymphopenia (<1.1 × 109/l), between the 2.5th and 97.5th percen-
tile as the reference range (1.1–3.7 × 109/l), and above the 97.5th percentile as lymphocytosis
(>3.7 × 109/l).
Infectious disease endpoints
Using the Danish National Patient Register [30] which covers all Danish hospitals, we obtained
information for each individual on hospitalizations and/or emergency room visits with a pri-
mary discharge diagnosis of an infectious disease. We collected this information until
Lymphopenia and risk of infections
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November 14, 2014. Information on emigration (n = 385) and vital status and date of emigra-
tion/death until November 14, 2014, was retrieved from the Danish Civil Registration System.
For individuals who died before November 14, 2014, information on infection-related
deaths was obtained from the national Danish Register of Causes of Death [31], which covers
all deaths in Denmark and registers all listed diagnoses on the death certificate as contributors
to death according to the treating physician.
Infectious disease diagnoses were classified according to the World Health Organization’s
International Statistical Classification of Diseases–10th Revision (ICD-10), and collapsed into
the following 7 categories: pneumonia, skin infection, urinary tract infection, sepsis, diarrheal
disease, endocarditis, and other infections (Table A in S1 Appendix). Of note, hospitalizations
due to HIV/AIDS were not included in any of the infectious disease categories, since a low
lymphocyte count in combination with a high risk of infection is characteristic for this disease.
To investigate whether the Danish National Patient Register records infectious disease diagno-
ses correctly, a medical doctor specializing in infectious diseases validated 141 admissions
coded as infections in the registry, and 139 of 141 admissions fulfilled the following criteria:
(1) relevant signs and symptoms of infection, (2) a positive culture, and/or (3) treatment with
antibiotics [32].
Comorbidities
Noninfectious comorbidities could possibly confound the association between lymphopenia
and risk of infection, since various malignancies and systemic autoimmune diseases and their
respective treatments are associated with both a high risk of infection and a low lymphocyte
count [9,14,15,33,34]. We therefore adjusted for the Charlson comorbidity index [35], a sever-
ity-weighted index of comorbid conditions that considers both the number and severity of
comorbid diseases. This index has been validated for its ability to predict mortality [36,37]. We
retrieved information from the Danish National Patient Register on inpatient hospitalizations,
emergency room visits, and outpatient visits regarding the following disease categories: AIDS/
HIV, any malignancy (including lymphoma and leukemia, except malignant neoplasms of the
skin), cerebrovascular disease, chronic pulmonary disease, congestive heart failure, dementia,
diabetes without chronic complications, diabetes with chronic complications, hemiplegia/
paraplegia, metastatic solid tumors, mild liver disease, moderate/severe liver disease, myocar-
dial infarction, peptic ulcer disease, peripheral vascular disease, renal disease, and rheumatic
disease, using ICD-10 codes previously published [37], and as previously done [18]. This was
done to reduce the possible confounding effect of comorbidities on the association between
lymphopenia and risk of infection and infection-related death.
To exclude that the observed association was due to individuals having immunodeficiency/
hematologic disease or autoimmune disease [38], information on diagnoses of immunodefi-
ciencies, hematologic diseases, and autoimmune diseases was retrieved from the Danish
National Patient Register using the ICD-10 codes shown in Tables B and C in S1 Appendix.
Individuals with HIV infection were categorized as being immunodeficient and included in all
main analyses.
Statistical analyses
Statistical analyses were performed using Stata version 13.1. All statistical tests were 2-sided,
and p-values < 0.05 were considered statistically significant. Jointly among all authors before
study initiation, analyses were planned and adjustment variables were decided upon before
analyses were conducted. The only change to the initial analysis plan was the inclusion of the
Charlson comorbidity index and information on immunodeficiency/hematologic disease, to
Lymphopenia and risk of infections
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account for potential confounders associated with both lymphocyte count and risk of infec-
tion. Also, comments from reviewers prompted additional sensitivity analyses to be conducted
and information on autoimmune diseases to be included in the multivariable adjusted model.
Differences in baseline characteristics were assessed using Cuzick’s extension to the Wilcoxon
rank-sum test for continuous variables and logistic regression for categorical variables. Corre-
lations between lymphocyte count and covariates were calculated using Spearman’s rank
correlation.
To estimate the stability of blood lymphocyte counts, we calculated regression toward the
mean using the lymphocyte count at the initial date of examination (the 2003 examination,
from 2003–2004) and the lymphocyte count after a median of 10.5 years (the 2013 examina-
tion, from 2013–2014) in 5,181 individuals who had repeat measurements performed. The
regression dilution ratio was calculated according to Clarke et al. [39]. In our study, the ratio
was based on the median value in the groups with lymphopenia and lymphocytosis, using the
2.5th and 97.5th percentile cutoffs for lymphocytes at the date of examination, and was calcu-
lated to 0.68 (Fig 2). This analysis was not planned before first analyses, but performed after
first results were known.
Fig 2. Regression toward the mean of lymphocyte counts, categorized as lymphopenia (<1.1 × 109/l), reference lymphocyte count (1.1–
3.7 × 109/l), and lymphocytosis (>3.7 × 109/l) at the date of examination in 2003 in the Copenhagen General Population Study. When
categorizing lymphocyte counts, lymphopenia was defined as a lymphocyte count below the 2.5th percentile, the reference category was
defined as a lymphocyte count between the 2.5th and 97.5th percentile, and lymphocytosis was defined as a lymphocyte count above the
97.5th percentile. Median values and interquartile ranges of 5,181 individuals at the 2003 examination (left) and the same individuals—
maintaining the 2003 categorization—at the 2013 examination (right). Regression dilution ratio is 2.04/2.98 = 0.68. The table below the graph
gives the percentage of individuals in each lymphocyte category at the 2003 examination (rows) and at the 2013 examination (columns).
https://doi.org/10.1371/journal.pmed.1002685.g002
Lymphopenia and risk of infections
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002685 November 1, 2018 6 / 22
Risk of infectious disease hospitalization and risk of infection-related death were modeled
separately using Cox proportional hazards regression with left-truncated age as the timescale,
implying that age is automatically adjusted for. For presentation of results from the Cox mod-
els, hazard ratios and 95% confidence intervals according to continuous levels of lymphocyte
counts were modeled using restricted cubic splines. The number of knots for the splines,
between 3 and 7, was chosen according to which number of knots had the lowest value of
Akaike’s information criterion [40]; if Akaike’s information criterion values were within 2 of
each other for different numbers of knots, the lowest number of knots was chosen. In this
study, all cubic splines are presented with 5 knots. Risk estimates are also presented with lym-
phocyte counts categorized into 3 groups: lymphopenia was defined as a lymphocyte count
below the 2.5th percentile, the reference category was defined as a lymphocyte count between
the 2.5th and 97.5th percentile, and lymphocytosis was defined as a lymphocyte count above
the 97.5th percentile. For the analysis of lymphocyte count and risk of infectious disease hospi-
talization, follow-up began at the date of examination and ended on the date of infectious dis-
ease hospitalization, death due to any cause (n = 5,636), emigration (n = 385), or November
14, 2014, whichever came first. For the analysis of lymphocyte count and risk of infection-
related death, follow-up began at the date of examination and ended on date of infection-
related death, death due to another cause, emigration, or November 14, 2014, whichever came
first. Interactions were tested for using a likelihood ratio test. These analyses were planned
before initiation of the study.
Apart from age as the underlying timescale, multivariable models were additionally
adjusted for sex and values at baseline of smoking status, cumulative smoking in pack-years,
alcohol consumption, body mass index, plasma C-reactive protein, blood neutrophil count,
recent infection, Charlson comorbidity index, autoimmune diseases, medication use, and
immunodeficiency/hematologic disease. These adjustments were planned before initiation of
the study, except for the inclusion of the Charlson comorbidity index and autoimmune dis-
eases, which were added to the model at a later stage.
Information on age, sex, blood neutrophil count, Charlson comorbidity index, autoim-
mune diseases, and immunodeficiency/hematologic disease was available on all individuals.
For the remaining covariates, information was more than 98% complete. Missing data were
coded as missing for the categorical variables smoking status, alcohol consumption, body mass
index, recent infection, and medication use, while missing data for the continuous variables
cumulative smoking and plasma C-reactive protein were imputed based on age, sex, and, for
cumulative smoking, smoking status using linear regression. However, when only individuals
with complete information on all covariates were included, results were similar to those
reported.
Sensitivity analyses
Hypothetically, an association between lymphopenia and increased risk of future infection
could be due to subclinical infections present, but not yet diagnosed, at the time of blood sam-
pling. To test the robustness of the association, we therefore subdivided follow-up time into
the following 3 time intervals after blood sampling: 0–2 years, more than 2 and up to 4 years,
and more than 4 years. This analysis was prespecified, as done earlier [18].
Furthermore, we examined whether comorbidities diagnosed after the date of examination
could explain the association between lymphopenia and risk of infection, accounting for any
comorbidity undiagnosed at the date of examination. This sensitivity analysis was performed
by including the Charlson comorbidity index as a time-dependent variable in the multivariable
adjusted model, using continuously updated information on comorbidities during follow-up
Lymphopenia and risk of infections
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retrieved from the Danish National Patient Register. This analysis was not planned before first
analyses, but performed after first results were known.
Individuals infected with HIV/AIDS could potentially confound our analyses, since these
individuals have low lymphocyte counts in combination with a high risk of infection. To test
the impact of this confounder, we conducted a sensitivity analysis excluding all individuals
diagnosed with HIV/AIDS at date of examination or during follow-up (n = 12). This analysis
was not planned before first analyses, but prompted by editors’ comments.
Clinical relevance of lymphopenia for predicting risk of infection in
individual persons
To predict an individual’s risk of future hospitalization due to infection, we performed receiver
operating characteristic curve analyses, evaluating the sensitivity and specificity of different
blood lymphocyte cutoffs to predict hospitalization due to infection within 2 years of blood
sampling. The analyses were done using at first only the lymphocyte count and then the lym-
phocyte count taking age, sex, and smoking status into account. To further help clinicians in
their evaluation of individuals with lymphopenia, we made a prediction algorithm for absolute
2-year risk of hospitalization due to infection, stratified according to other infectious disease
risk factors. Inclusion of other infectious disease risk factors in the prediction algorithm was
based on the multivariable adjusted model, as we only included risk factors with a significant
interaction test in the prediction algorithm. To estimate absolute 2-year risk of infectious dis-
ease hospitalization, we used Poisson regression models. Importantly, all individuals with
immunodeficiency, hematologic disease, and/or autoimmune disease were not included in the
algorithm or the receiver operating characteristic curve analyses, since these individuals have a
well-known high risk of infection. These analyses were not planned before first analyses, but
prompted by reviewers’ comments.
Results
Baseline characteristics recorded at the date of examination for 98,344 individuals from the
Copenhagen General Population Study are shown in Table 1. All characteristics were indepen-
dently associated with risk of infection. Lymphocyte counts are presented in Fig A in S1
Appendix. Lymphopenia was defined as a lymphocyte count below the 2.5th percentile of the
population distribution (<1.1 × 109/l).
Among 5,181 individuals with blood lymphocyte counts at both the 2003 and 2013 exami-
nation, 27% of those who had lymphopenia at the 2003 examination still had it at the 2013
examination (Fig 2). The median blood lymphocyte count in individuals with lymphopenia
was 1.02 × 109/l (IQR 0.96–1.06) at the 2003 examination, while the corresponding value in
the same individuals measured 10 years later at the 2013 examination was 1.19 × 109/l (IQR
1.08–1.40). These values together with the values for individuals with lymphocytosis gave a
regression dilution ratio of 0.68 (2.04/2.98; see Fig 2). Notably, 84% of those who had lympho-
penia at the 2003 examination had lymphocyte count < 1.5 × 109/l at the 2013 examination.
Likewise important, among individuals without lymphopenia at the 2003 examination, 2% had
lymphopenia at the 2013 examination.
Lymphopenia and risk of infection
During a median follow-up of 6 years (range 0–11 years), 8,401 individuals were hospitalized
due to infection. After adjusting for age and sex, the hazard ratio for any infection was 1.67
(95% CI 1.52–1.84) in individuals with lymphopenia and 1.40 (95% CI 1.24–1.58) in individu-
als with lymphocytosis, when compared to individuals with lymphocytes in the reference
Lymphopenia and risk of infections
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range (Fig 3). In the multivariable adjusted model, corresponding hazard ratios were 1.41
(95% CI 1.28–1.56) and 1.08 (95% CI 0.96–1.22).
The spline curves in Fig 3 illustrate the change in hazard ratios and 95% confidence inter-
vals for risk of any infection as a function of blood lymphocyte count on a continuous scale.
The reference value, i.e., where the hazard ratio is set to 1.0, is the median lymphocyte count
for the entire population (2.1 × 109/l), and smoothed curves that best fit the data are shown.
Fig 3 shows that at blood lymphocyte counts below 1.4 × 109/l, the multivariable adjusted haz-
ard ratio for any infection increases sharply with lower and lower lymphocyte counts, ulti-
mately reaching 2.16 at lymphocyte counts of 0.1 × 109/l. At blood lymphocyte counts above
the median value, the hazard ratio for any infection did not differ from 1.0 in the multivariable
adjusted model.
For specific types of infections, individuals with lymphopenia versus those with lympho-
cytes in the reference range had multivariable adjusted hazard ratios (95% CIs) of 1.31 (1.14–
1.52) for pneumonia, 1.44 (1.15–1.79) for skin infection, 1.26 (1.02–1.56) for urinary tract
Table 1. Baseline characteristics of 98,344 individuals from the Copenhagen General Population Study according to blood lymphocyte count.
Characteristic Blood lymphocyte count p for trenda Correlation with
blood lymphocyte
count
Lymphopenia
(<1.1 × 109/l)
Reference (1.1–
3.7 × 109/l)
Lymphocytosis
(>3.7 × 109/l)
r p
Individuals, number (%) 2,352 (2.4) 93,538 (95.1) 2,454 (2.5) — — —
Blood lymphocyte count, ×109/l (range) 1.0 (0.1–1.1) 2.1 (1.1–3.7) 4.0 (3.7–125.2) — — —
Age, years (IQR) 68 (58–77) 58 (48–67) 57 (48–66) 2 × 10−75 −0.16 <1 × 10−300
Male sex, number (%) 1,303 (55) 41,957 (45) 921 (38) 2 × 10−30 — —
Ever smokers, number (%) 1,364 (58) 53,972 (58) 1,842 (75) 2 × 10−50 — —
Cumulative smoking, pack-yearsb (IQR) 16 (5–33) 15 (6–30) 26 (14–40) 6 × 10−104 0.12 <1 × 10−300
Alcohol consumption >168/84 g/weekc, number
(%)
955 (41) 36,803 (39) 884 (36) 0.01 — —
Body mass index, kg/m2 (IQR) 25 (23–28) 26 (23–28) 27 (24–30) 4 × 10−54 0.12 <1 × 10−300
Plasma C-reactive protein, mg/l (IQR) 1.6 (1.0–3.4) 1.4 (1.0–2.2) 1.9 (1.3–3.4) 3 × 10−32 0.09 4 × 10−170
Blood neutrophil count, × 109/l (IQR) 3.7 (2.9–4.8) 4.0 (3.3–4.9) 5.0 (4.1–6.1) 3 × 10−244 0.21 <1 × 10−300
Any recent infection, number (%) 131 (6) 3,658 (4) 131 (5) 0.63 — —
Any comorbidityd, number (%) 1,114 (47) 18,892 (20) 565 (23) 5 × 10−41 — —
Charlson score 1 or 2 808 (34) 16,262 (17) 485 (20) 2 × 10−21 — —
Charlson score > 2 306 (13) 2,639 (3) 80 (3) 2 × 10−48 — —
Any autoimmune disease, number (%) 298 (13) 4,252 (5) 117 (5) 4 × 10−19 — —
Any medication, number (%) 1,743 (74) 52,384 (56) 1,540 (63) 0.002 — —
Any immunodeficiency/hematologic diseasef,
number (%)
250 (11) 2,220 (2) 130 (5) 1 × 10−6 — —
Values are median for continuous variables and frequency for categorical variables. When categorizing lymphocyte counts, lymphopenia was defined as a lymphocyte
count below the 2.5th percentile, the reference category was defined as a lymphocyte count between the 2.5th and 97.5th percentile, and lymphocytosis was defined as a
lymphocyte count above the 97.5th percentile.
ap for trend was calculated with Cuzick’s extension of the Wilcoxon rank-sum test (continuous variables) or logistic regression (categorical variables). Correlations (r,
and p-values) between covariates and lymphocyte count were calculated with Spearman’s correlation.
bOnly ever smokers.
c>168 g/week for men and >84 g/week for women, following the Danish Health Authority.
dAs defined by the Charlson comorbidity index.
fHIV/AIDS is included in the immunodeficiency category.
https://doi.org/10.1371/journal.pmed.1002685.t001
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infection, 1.51 (1.21–1.89) for sepsis, 1.38 (1.01–1.88) for diarrheal disease, 2.15 (1.16–3.98) for
endocarditis, and 2.26 (1.21–4.24) for other infections (Fig 4).
Results were similar to those presented in Fig 4 if lymphopenia was defined using other
commonly applied international cutoffs for lymphopenia (<1.0 or<1.5 × 109/l) (Figs B and C
in S1 Appendix). When adjusting the analysis for regression dilution bias, we found a multi-
variable adjusted hazard ratio of 1.65 (95% CI 1.43–1.91) for any infection in individuals with
lymphopenia compared to individuals with lymphocytes in the reference range (Fig D in S1
Appendix).
Stratified analyses
To examine the robustness of the association between lymphopenia and risk of any infection,
we performed stratified analyses according to strata of the covariates that were associated with
lymphocyte counts at baseline (Fig 5). Risk of any infection in those with lymphopenia versus
those with lymphocytes in the reference range was higher in individuals aged�60 years than
in those aged>60 years (p for interaction = 0.005). Risk of any infection in those with lympho-
penia versus those with lymphocytes in the reference range was higher in those with immuno-
deficiency/hematologic disease than in those without (p for interaction < 0.001) at date of
examination. Importantly, however, risk of any infection in those with lymphopenia was still
elevated in individuals aged>60 years and in those without immunodeficiency/hematologic
disease. To further explore the interaction with age, we redefined lymphopenia by calculating
Fig 3. Risk of any infection as a function of lymphocyte count for individuals from the Copenhagen General Population Study. Solid red lines are hazard ratios,
and dashed black lines indicate 95% confidence intervals based on fitting of cubic splines to risk estimates obtained using Cox proportional hazards regression.
Multivariable adjustment includes all covariates listed in Table 1 except age, but with age as the underlying timescale. The median lymphocyte value of 2.1 × 109/l was set
as reference for the continuous model. For the multivariable adjusted model, the lymphocyte interval 30–40 × 109/l is added to illustrate that for very high lymphocyte
counts the risk of infections increases, but with a broad confidence interval. When categorizing lymphocyte counts, lymphopenia was defined as a lymphocyte count
below the 2.5th percentile, the reference category was defined as a lymphocyte count between the 2.5th and 97.5th percentile, and lymphocytosis was defined as a
lymphocyte count above the 97.5th percentile.
https://doi.org/10.1371/journal.pmed.1002685.g003
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Fig 4. Multivariable adjusted risks of specific infections as a function of lymphocyte count for individuals from the Copenhagen
General Population Study. Solid red lines are multivariable adjusted hazard ratios, and dashed black lines indicate 95% confidence
intervals based on fitting of cubic splines to risk estimates obtained using Cox proportional hazards regression. Multivariable adjustment
includes all covariates listed in Table 1 except age, but with age as the underlying timescale. The median lymphocyte value of 2.1 × 109/l was
set as reference for the continuous model. The sum of the numbers of cases of specific infections exceeds the number of cases of “any
infection” since individuals could have more than 1 specific infection. When categorizing lymphocyte counts, lymphopenia was defined as a
lymphocyte count below the 2.5th percentile, the reference category was defined as a lymphocyte count between the 2.5th and 97.5th
percentile, and lymphocytosis was defined as a lymphocyte count above the 97.5th percentile.
https://doi.org/10.1371/journal.pmed.1002685.g004
Fig 5. Multivariable adjusted risk of any infection for individuals from the Copenhagen General Population Study with lymphopenia (lymphocyte
count< 1.1 × 109/l) compared to individuals with lymphocytes in the reference range (1.1–3.7 × 109/l). Multivariable adjustment includes all covariates listed
in Table 1 except age, but with age as the underlying timescale. The sum number of individuals in the strata varies slightly because of varying numbers of
individuals with missing data in the covariates. When categorizing lymphocyte counts, lymphopenia was defined as a lymphocyte count below the 2.5th percentile,
while the reference category was defined as a lymphocyte count between the 2.5th and 97.5th percentile. NSNot significant after adjusting for 12 multiple
comparisons using the Bonferroni method.aAccording to a likelihood ratio test.b�168 versus>168 g/week for men and�84 versus>84 g/week for women.cWhen
categorizing neutrophil counts, neutropenia was defined as a neutrophil count below 1.5 × 109/l, which is the generally accepted lower cutoff [4,41–43], the
reference category was defined as a neutrophil count from 1.5 × 109/l to 5.9 × 109/l, and neutrocytosis was defined as a neutrophil count above 5.9 × 109/l.dAs
defined by the Charlson comorbidity index.
https://doi.org/10.1371/journal.pmed.1002685.g005
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the age-adjusted 2.5th percentile for lymphocyte count for each 1-year age span. When using
these age-adjusted 2.5th percentiles as the cutoff for lymphopenia, lymphopenia was still asso-
ciated with increased risk of any infection, with a hazard ratio of 1.49 (95% CI 1.32–1.68), but
there was no longer an interaction between age and lymphopenia (p = 0.54) on risk of any
infection (Fig 6).
Sensitivity analyses
To examine whether the observed association was due to reverse causation or heavily con-
founded by undiagnosed comorbidities at baseline, we subdivided follow-up time into the fol-
lowing 3 time intervals after blood sampling: 0–2 years, more than 2 and up to 4 years, and
more than 4 years (Fig 7). Although the risk estimate was attenuated with increasing time
from the date of examination (p for interaction = 0.002), risk was still increased more than 2
years after the date of examination and onwards. When taking comorbidities diagnosed after
the date of examination into consideration, the association between lymphopenia and risk of
any infection was only slightly attenuated (Fig E in S1 Appendix).
Of 98,344 individuals included, only 12 were infected with HIV/AIDS at the date of exami-
nation or during follow-up. When we excluded these individuals from the main multivariable
adjusted analysis, results were similar (Fig F in S1 Appendix).
Clinical relevance of lymphopenia for predicting risk of infection in
individual persons
To examine lymphopenia as a tool to predict an individual’s risk of future hospitalization due
to infection, we performed receiver operating characteristic curve analyses, evaluating the sen-
sitivity and specificity of different blood lymphocyte cutoffs to predict hospitalization due to
infection within 2 years of blood sampling (Figs G and H in S1 Appendix). Generally, when
using a low blood lymphocyte cutoff (i.e., 1.1 × 109/l), the specificity was high, but the
Fig 6. Multivariable adjusted risk of any infection for individuals from the Copenhagen General Population Study with lymphopenia using age-adjusted
percentiles of lymphocyte count. Multivariable adjusted risk of any infection for individuals from the Copenhagen General Population Study with lymphopenia
(lymphocyte count< 1.1 × 109/l) compared to individuals with lymphocytes in the reference range (1.1–3.7 × 109/l). Multivariable adjustment includes all covariates
listed in Table 1 except age, but with age as the underlying timescale. Individuals with lymphopenia had a lymphocyte count below the 2.5th percentile in each 1-year
age band. aAccording to a likelihood ratio test.
https://doi.org/10.1371/journal.pmed.1002685.g006
Lymphopenia and risk of infections
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002685 November 1, 2018 13 / 22
sensitivity was low, indicating that for very low lymphocyte counts, an individual was likely to
be admitted to hospital due to an infection, but that a high proportion of infectious disease
hospitalizations occurred in individuals without lymphopenia. As low blood lymphocyte
count only explains a small proportion of infectious disease hospitalizations in the overall pop-
ulation, lymphocyte count alone could not convincingly predict risk of infection in most indi-
viduals, as illustrated by an area under the curve of 0.55 (95% CI 0.54–0.56) (Fig G in S1
Appendix), and when further taking age, sex, and smoking status into account, results were
similar (Fig H in S1 Appendix). However, when we developed a prediction algorithm taking
age, sex, and smoking status into account, we were able to differentiate individuals with high
absolute 2-year risk of infection from those with very low risk (Fig 8). Based on inspiration
from the Framingham Risk Score for predicting risk of cardiovascular disease, our algorithm
predicts absolute 2-year risk of hospitalization due to any infection, taking lymphocyte count,
Fig 7. Multivariable adjusted risk of any infection for individuals from the Copenhagen General Population Study with lymphopenia
stratified by follow-up time. Multivariable adjusted risk of any infection for individuals from the Copenhagen General Population Study
with lymphopenia (lymphocyte count< 1.1 × 109/l) compared to individuals with lymphocyte count in the reference range (1.1–3.7 × 109/l).
Multivariable adjustment includes all covariates listed in Table 1 except age, but with age as the underlying timescale. Follow-up time was
segmented into 3 time intervals, and each individual was included in more than 1 time interval if total follow-up was above 2 years. When
categorizing lymphocyte counts, lymphopenia was defined as a lymphocyte count below the 2.5th percentile, while the reference category
was defined as a lymphocyte count between the 2.5th and 97.5th percentile. aAccording to a likelihood ratio test.
https://doi.org/10.1371/journal.pmed.1002685.g007
Fig 8. Algorithm. Absolute 2-year risks of hospitalization due to infection for different blood lymphocyte categories, stratified for age, sex, and smoking status.
Nonsmokers were former smokers and never-smokers combined. Individuals diagnosed with immunodeficiency, hematologic disease, and/or autoimmune disease were
not included when calculating absolute risks for the algorithm, since these individuals have a well-known high risk of infection. Numbers indicate absolute 2-year risk as
rounded percentages.
https://doi.org/10.1371/journal.pmed.1002685.g008
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age, sex, and smoking status into account. As seen in Fig 8, the combination of lymphopenia
with other risk factors enables the algorithm to categorize individuals into categories with
markedly different absolute 2-year risks of infection. For example, the highest absolute 2-year
risk of 42% was observed for male smokers aged>80 years with blood lymphocyte
count< 0.5 × 109/l. This means that nearly 1 in 2 individuals from this category will be admit-
ted to hospital due to an infectious disease within 2 years of the date of examination. In con-
trast, the lowest absolute 2-year risk was observed for nonsmokers aged<50 years with
lymphocyte count> 0.8 × 109/l, irrespective of sex.
Lymphopenia and infection-related death
The hazard ratio for infection-related death in individuals with lymphopenia versus those with
lymphocytes in the reference range was 1.70 (95% CI 1.37–2.10) in the multivariable adjusted
model (Fig 9).
Fig 9. Multivariable adjusted risk of infection-related death as a function of lymphocyte count for individuals from the
Copenhagen General Population study. The solid red line is the multivariable adjusted hazard ratio, and black dashed lines indicate
the 95% confidence interval based on fitting of cubic splines to risk estimates obtained using Cox proportional hazards regression.
Multivariable adjustment includes all covariates listed in Table 1 except age, but with age as the underlying timescale. The median
lymphocyte value of 2.1 × 109/l was set as reference for the continuous model. When categorizing lymphocyte counts, lymphopenia
was defined as a lymphocyte count below the 2.5th percentile, the reference category was defined as a lymphocyte count between the
2.5th and 97.5th percentile, and lymphocytosis was defined as a lymphocyte count above the 97.5th percentile.
https://doi.org/10.1371/journal.pmed.1002685.g009
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Discussion
In this prospective study of 98,344 individuals from the general population, we found that lym-
phopenia was associated with increased risk of hospitalization due to any infection, pneumo-
nia, skin infection, urinary tract infection, sepsis, diarrheal disease, endocarditis, and other
infections after adjusting for potential explanatory factors including blood neutrophil count.
Lymphopenia was also associated with a 1.7-fold increased risk of infection-related death.
These are novel findings. However, causality cannot be deduced from our data.
Comparison with other studies
There are surprisingly few studies on lymphopenia and risk of infection, and none of them
have studied individuals in the general population. One study found a 2.4-fold increased risk
of urinary tract infection and lower respiratory tract infection among 156 long-term facility
care residents with lymphopenia [33], and 2 studies with 167 and 91 participants found that
lymphopenia in patients with systemic autoimmune diseases was associated with a 5.2- and
4.7-fold increased risk of infection, respectively [14,15]. Further, a recent study examining 753
patients in intensive care units found that lymphopenia at admittance was associated with a
1.6-fold increased risk of infection, but there was no association between lymphopenia and
28-day mortality. However, persistent lymphopenia at day 3 after admittance was associated
with both a 1.4-fold increased risk of infection and a 1.7-fold increased risk of 28-day mortality
[44]. Discrepancies between the findings in the present and former studies [14,15,33] may be
due to our study design including general population individuals, versus case cohorts of fragile
or very sick individuals/patients. Also, as former studies were smaller than the present one,
effect sizes in previous studies may have needed to be larger than what we observed for the
results to be significant at the p< 0.05 level. Hence, due to potential publication bias, there
may have been a tendency for previous smaller studies to be published only if they reported
large effect sizes, while similar smaller studies with negative results may never have been pub-
lished. Such a scenario is well known in the medical literature, i.e., that the first relatively small
studies typically report larger effect sizes than later-published large or huge studies.
Strengths and limitations
Strengths of this study include the large study cohort and prospective design. Also, the 98,344
individuals from the general population with a blood lymphocyte count were followed without
losses to follow-up due to the unique Danish civil and health registers. Furthermore, we were able
to adjust for various potentially explanatory factors such as smoking, body mass index, alcohol
intake, plasma C-reactive protein, blood neutrophil count, recent infection, medication use, and
comorbidities including autoimmune disease and immunodeficiency/hematologic disease.
Potential limitations of our study should also be considered. This study is strictly observa-
tional and can therefore not address questions of causality, and our analyses might theoreti-
cally have been affected by reverse causation or confounding. However, since the association
between lymphopenia and risk of infection was observed even for any infection occurring
more than 2 years after the blood lymphocyte count, reverse causation is less likely to be the
only explanation of the results, although the attenuation after 2 years of follow-up might be a
sign of underlying conditions at time of examination. Confounding by lifestyle factors or other
yet unknown factors is also possible. In the multivariable adjusted analyses, we adjusted for
variation in known risk factors for infection; however, we naturally cannot exclude that other
known or unknown confounders could explain the association between lymphopenia and
risk of infection. Causality could be addressed in a randomized trial aimed at increasing lym-
phocyte counts; however, at present, such a trial is not feasible. Alternatively, a genetic
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Mendelian randomization study could address causality; however, we are not aware of suffi-
ciently strong genetic instruments to address this question in a study the size of ours. Impor-
tantly, from a clinical point of view, if the observed association is due to individuals with
lymphopenia actually having an undiagnosed comorbidity, this does not make the motivation
to follow these individuals less relevant.
Another potential limitation could be that individuals with lymphopenia were more likely
to be admitted to hospital by their general practitioner or the hospital staff than individuals
with lymphocytes in the reference range. However, for individuals with lymphopenia, the esti-
mates for risk of infection and risk of infection-related death were similar. Thus, we found no
indication that the severity of infection in patients with lymphopenia is reduced compared to
that in patients with lymphocytes in the reference range.
Stability of blood lymphocyte counts over the course of the study also needs to be
addressed. Using repeat measurements 10 years apart of blood lymphocyte counts in 5,181
individuals, we found that even though lymphocyte counts vary over time, most individuals
with lymphopenia at the date of the initial examination had lymphocyte counts below
1.5 × 109/l 10 years later. Conversely, some individuals moved from one lymphocyte category
to another after 10 years, and this could contribute to the attenuation of risk estimates
observed with longer follow-up periods. Regression dilution bias considers both measurement
and biological variability over time, and analyses adjusted for regression dilution bias gave
more pronounced results, but did not change the overall results.
Another potential bias is healthy participant bias because the 45% of invited individuals
who did participate were likely healthier than the non-participants. If that was the case, then
the observed association between lymphopenia and increased risk of infection possibly could
be underestimated. Lastly, the generalizability of our results to other populations may be
reduced by the fact that we only investigated white individuals of Danish descent; however, we
are not aware of data indicating that the results presented in this paper may be different in
other ethnic groups. Indeed, blood lymphocyte counts seem similar in different ethnicities
[45,46]. In the present study we did not include race as a variable for adjustment, as all individ-
uals included were white and of Danish descent.
Possible explanations and implications for clinicians
Circulating lymphocytes are 70%–80% composed of T lymphocytes, implying that lymphope-
nia is most likely a manifestation of a reduced number of T lymphocytes [13]. Circulating lym-
phocytes are a part of the extensive defense against microorganisms in the body, and
lymphocytes can be very long-living cells with memory functions, resulting in a quick recogni-
tion and eradication of microorganisms known to the immune system. Lymphocyte counts
decrease with increasing age, as also shown here, and the composition of lymphocyte subsets
changes as individuals age [47]. Other important age-related immune changes are the
impaired generation of primary CD8+ T cell responses against infections and reduced vaccine
efficacy [48–50]. Furthermore, older age is characterized by thymic involution and a decline in
naïve T and B cell output from the bone marrow, which leads to accumulation of memory T
cells that are late differentiated or senescent, with the majority specific for chronic virus infec-
tions such as cytomegalovirus or Epstein-Barr virus [51]. It is well known that the risk of infec-
tion increases with higher age, probably due to both acquired comorbidities and change in
overall immune competence, including alterations in lymphocyte subsets [52]. Previous stud-
ies have shown that the composition and kinetics of T lymphocyte subsets predict infections
[53], and in the setting of HIV and AIDS, it is well established that a low CD4+ cell count is a
major risk factor for opportunistic infections. Likewise, a decrease in T cell receptor diversity
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has been shown in HIV-infected individuals [54], indicating that T cell receptor diversity
might be dependent on the number and composition of circulating lymphocytes. Further-
more, T cell receptor signal transduction pathways are significantly altered with age, resulting
in impaired transcription of T cell genes [55]. In our study of the general population, we did
not measure specific lymphocyte subsets; thus, we do not know to what degree lymphopenia
was pronounced in each subset of lymphocytes. Nonetheless, based on the abovementioned
studies, it is plausible that lymphopenia in individuals from the general population may cause
a decrease in the T cell receptor repertoire, which might theoretically explain why these indi-
viduals experience a greater risk of infection.
Thus, an association between a low lymphocyte count and increased risk of infection physi-
ologically seems plausible, especially in aged individuals, but age alone cannot explain our
findings since all analyses were adjusted for age, and the analysis using age-specific cutoffs for
lymphopenia produced similar results.
In this study, we defined lymphopenia as a lymphocyte count below the 2.5th percentile in
the study population, and when using 2 widely implemented cutoffs—1.0 × 109/l and
1.5 × 109/l—results were similar, indicating that this is a robust finding.
Today doctors primarily evaluate only neutropenia in individuals from the general popula-
tion, due to the well-known high risk of infection [3]. A review from 2012 recommended screen-
ing individuals with neutrophil counts< 1.0 × 109/l for active or chronic infection with viruses,
bacteria, mycobacteria, and rickettsia; investigating possible drug-induced or autoimmune neutro-
penia; and performing a bone marrow biopsy for neutrophil counts< 0.5 × 109/l [4]. For lympho-
cyte counts< 1.0 × 109/l, the same review recommended screening for HIV and measurement of
immunoglobulins, but no further evaluation if these tests are normal. Thus, physicians are cur-
rently not recommended to intervene in individuals with “asymptomatic” lymphopenia without
an associated diagnosed disease. To evaluate whether lymphopenia may be useful to clinicians for
predicting an individual’s absolute risk of future infection, we developed a prediction algorithm to
determine absolute 2-year risk of hospitalization due to any infection in individuals from the gen-
eral population with low lymphocyte counts. The 2-year risk estimates vary from 1% to 42%, with
the highest risk observed in older male smokers with lymphocyte counts< 0.5 × 109/l. Our algo-
rithm indicates that prevention or early detection of infections in individuals with lymphopenia
may be especially relevant to implement for individuals who have other concurrent risk factors
(e.g., male sex, high age, smoking), as these individuals can have a very high absolute risk of infec-
tious disease hospitalization. Hence, the usefulness of combining several risk factors resembles
that of the well-known Framingham Risk Score for prediction and prevention of cardiovascular
disease [56]. The results from the present study could indicate that individuals with lymphopenia
might benefit from additional medical attention because of their increased risk of infection as well
as increased risk of infection-related death.
Conclusion
Of the invited 220,424 individuals, 99,191 attended examination. In the 98,344 individuals
from the general population with a valid lymphocyte count, lymphopenia, defined as blood
lymphocytes < 1.1 × 109/l, was associated with a 1.4-fold increased risk of later hospitalization
with infection and a 1.7-fold increased risk of infection-related death. Importantly, causality
cannot be deduced from our data.
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